MIL •
Healthcare •
Drug Manufacturers - General •
Quote as of 08/21/2026 17:35
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeMIL
Market Capitalization198,222 mln
Float539 mln
Earnings Date11/03/2026
EPS
13.90
Robust
P / E
26.68
Elevated
Piotroski F-Score
8
/ 9
Very strong
Beneish M-Score
-2.62
Likely reliable
Relative Strength
94
/ 100
Top performer
Debt / Equity
4.90
Highly leveraged
Business Description
Amgen is a global biotechnology company founded in 1980 and based in Thousand Oaks, California, that researches, produces, and sells medicines designed to treat serious illnesses such as cancer, arthritis, osteoporosis, and blood disorders. Its broad portfolio includes dozens of established and emerging therapies sold through wholesale pharmaceutical distributors to hospitals, clinics, and pharmacies around the world. The company works alongside partners including AstraZeneca, UCB, and BeiGene to expand the reach and development of several key products.
